Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx Group (MDXG) Enterprise Value: 2011-2025

Historic Enterprise Value for Mimedx Group (MDXG) over the last 15 years, with Sep 2025 value amounting to $890.7 million.

  • Mimedx Group's Enterprise Value rose 14.36% to $890.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $561.0 million, marking a year-over-year decrease of 3.17%. This contributed to the annual value of $1.3 billion for FY2024, which is 16.58% up from last year.
  • Per Mimedx Group's latest filing, its Enterprise Value stood at $890.7 million for Q3 2025, which was up 13.67% from $783.6 million recorded in Q2 2025.
  • In the past 5 years, Mimedx Group's Enterprise Value ranged from a high of $1.3 billion in Q2 2021 and a low of $250.0 million during Q4 2022.
  • Moreover, its 3-year median value for Enterprise Value was $890.7 million (2025), whereas its average is $891.4 million.
  • As far as peak fluctuations go, Mimedx Group's Enterprise Value tumbled by 75.56% in 2022, and later soared by 349.14% in 2023.
  • Quarterly analysis of 5 years shows Mimedx Group's Enterprise Value stood at $590.3 million in 2021, then tumbled by 57.64% to $250.0 million in 2022, then soared by 349.14% to $1.1 billion in 2023, then increased by 16.58% to $1.3 billion in 2024, then increased by 14.36% to $890.7 million in 2025.
  • Its Enterprise Value was $890.7 million in Q3 2025, compared to $783.6 million in Q2 2025 and $1.0 billion in Q1 2025.